These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19967748)

  • 1. Growth inhibition of SK-MEL-30 human melanoma cells by antisense c-myc oligonucleotides delivered by poly(N-isopropylacrylamide)/ poly(ethyleneimine) copolymer.
    Dinçer S; Oskay EK; Piskin AK; Zeybek ND; Pişkin E
    J Tissue Eng Regen Med; 2010 Jun; 4(4):284-90. PubMed ID: 19967748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P; Geiser TA; Ombres D; Citro G
    Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
    Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
    Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
    J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of cell proliferation and C-myc cancer protein expression in human colon adenocarcinoma cell line HT29 with VIP-131I-ASON].
    Ou X; Tan T; Li Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1096-100. PubMed ID: 17121362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression.
    Stewart DA; Xu X; Thomas SD; Miller DM
    Nucleic Acids Res; 2002 Jun; 30(11):2565-74. PubMed ID: 12034846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation.
    Capeáns C; Piñeiro A; Domínguez F; Loidi L; Buceta M; Carneiro C; Garcia-Caballero T; Sanchez-Salorio M
    Exp Eye Res; 1998 May; 66(5):581-9. PubMed ID: 9628805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G3139 induces cell death by caspase-dependent and -independent apoptosis on human melanoma cell lines.
    Nakamura S; Inui M; Kamei T; Nakase M; Okumura K; Tagawa T
    Oncol Rep; 2006 Jun; 15(6):1563-8. PubMed ID: 16685396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
    Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation.
    Stewart DA; Thomas SD; Mayfield CA; Miller DM
    Nucleic Acids Res; 2001 Oct; 29(19):4052-61. PubMed ID: 11574688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targeting delivery effect of galactose receptor-mediated c-myc antisense oligonucleotide on human hepatocellular carcinoma cell line Bel-7402].
    Jiang JW; Zhang Y
    Ai Zheng; 2004 Nov; 23(11):1288-93. PubMed ID: 15522175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.